Skip to main content
Caplight Logo









NeuroFlex

NeuroFlex

Private
MontrealHealthcare & Life Scienceshttps://neuroflex.io/

Last Round

VC Round

Apr 13, 2022

Total Funding Raised

$10,000

Company Overview

NeuroFlex is a health technology company that has developed a virtual reality-based, eye-tracking platform designed for the evaluation of brain function.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, AR/VR Experiences, Healthcare Analytics, Sports & Fitness

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

concussion managementVR assessmentoculomotor testingvestibular assessmentVR healthcarebrain health trackingeye-tracking softwareneurological trainingcognitive assessmentsports performance trackingSaaSbrain injury screeningconcussion protocoldigital healthneurotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NeuroFlex Comparables

Compare NeuroFlex with similar companies based on industry and business-model similarity.

NeuroFlex comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
REACT Neuro
90%
NeuroSync
89%
RightEye
81%

NeuroFlex Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundApr 13, 2022
SeedJun 12, 2019
GrantMar 30, 2017

Key People

Founding team and executive leadership

Grenville Thynne

CEO And Managing Director

Executive Team

NeuroFlex Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 30, 2017

    $10K grant received from National Bank of Canada and McGill Dobson Centre.

NeuroFlex Filings

Explore SEC and related filing metadata, where available.

NeuroFlex filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about NeuroFlex's valuation, stock price, and market status.

Is NeuroFlex a public or private company?

NeuroFlex is a private company.

What is the current stock price of NeuroFlex?

NeuroFlex is a private company with no public stock price. No recent secondary market data is available.

How much is NeuroFlex worth (valuation)?

Valuation information for NeuroFlex is not publicly available.

Can I buy NeuroFlex stock?

NeuroFlex shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was NeuroFlex's last funding round?

NeuroFlex's most recent funding round was VC Round on April 13, 2022.

Who are the main investors in NeuroFlex?

Key investors in NeuroFlex include Powerhouse Ventures, MEDTEQ+.

Will NeuroFlex IPO soon?

No public IPO plans have been announced for NeuroFlex.

How can I track NeuroFlex secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NeuroFlex's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMontreal
Employee Range18
Year Founded2016
Last FundingApr 13, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?